论文部分内容阅读
乙型肝炎(HBV)是严重危害人类健康的传染病,在感染了HBV的人群中,原发性肝癌的发病率比非感染人群高200倍[1]。因此研制特异的抗HBV药物十分重要。然而HBV病毒具有极窄的宿主范围,它仅在人和黑猩猩中感染和复制[2]。Ueda首用细胞系(HB611
Hepatitis B (HBV) is an infectious disease that seriously harms human health. In people infected with HBV, the incidence of primary liver cancer is 200 times higher than that of non-infected people [1]. Therefore, it is very important to develop specific anti-HBV drugs. However, the HBV virus has a very narrow host range and it only infects and replicates in humans and chimpanzees [2]. Ueda first cell line (HB611